Goodman is pleased to announce that the Goodman Foundation (“Foundation”) is the exclusive global partner for Steptember 2016, the major fundraising initiative of Cerebral Palsy Alliance. The new partnership builds …read more
Goodman is pleased to announce that the Goodman Foundation (“Foundation”) is the exclusive global partner for Steptember 2016, the major fundraising initiative of Cerebral Palsy Alliance. The new partnership builds on the Foundation’s ongoing global support of Steptember since 2014 and is being promoted as “Count Us In”, an inclusive and engaging campaign created to encourage Goodman’s employees and business partners, such as customers, agents and suppliers to make a meaningful difference. Count Us In encourages participation in Steptember, with a number of events and activities planned in the lead up to the event that support awareness, recruitment and fundraising.
Now in its sixth year, Steptember is a 28 day event focused on increasing daily activity levels and attracts participants from Australia, across the Asia Pacific region, to Europe and the United States. Teams of four people are encouraged to walk 10,000 steps (or equivalent activity) each day throughout September to help improve health and wellbeing, while raising funds and awareness of cerebral palsy.
Greg Goodman, Goodman Group CEO and a director of the Goodman Foundation said, “The Goodman Foundation is very proud to be the exclusive global partner of Steptember 2016. We have supported Cerebral Palsy Alliance since 2003 through various initiatives and are delighted that our new partnership will help take Steptember to the next level. I invite other corporates, together with small businesses and clubs, to make Steptember their wellness and charity event for the year. It’s a fun event that everyone can participate in, while providing valuable support for such a great cause.”
Every 15 hours an Australian child is born with cerebral palsy, making it the most common physical disability in childhood. There is no known cure for cerebral palsy. Steptember raises money to help kids and adults living with cerebral palsy lead the most fulfilling, independent and inclusive life possible. Cerebral Palsy Alliance does this by working with individuals and families to maximise their participation in the community and ensure people with cerebral palsy have access to high quality and innovative services and therapies.
Rob White, CEO, Cerebral Palsy Alliance said, “I would like to personally recognise and thank Goodman for their long standing support and contribution to Cerebral Palsy Alliance and Steptember. Our partnership with Goodman began some 13 years ago, and I am delighted to have Goodman’s support this year as exclusive global partner for Steptember 2016. Over the years Goodman have been instrumental in helping us raise vital funds to support our mission to build better futures for individuals living with disability:”
More than A$20 million has been raised around the world since the first Steptember event in 2010. Significantly, almost half of the total funds raised to date have come from Australia and Steptember has grown to become Australia’s leading charity health and wellness event.
With employees from more than 1,800 organisations globally expected to participate in 2016, this year’s event will be the biggest yet and a goal to raise A$5 million has been set. Funds raised will go towards providing vital equipment, therapy and services to children and adults living with cerebral palsy or help fund ground-breaking research into the prevention, treatment and ultimately a cure for cerebral palsy.
So why not register your team today on www.steptember.org.au?
In the lead up to Steptember, Goodman will be undertaking a number of fundraising activities around the world for this great cause, so watch this space and look for opportunities to get involved and show your support.
– Ends –
For further information, please contact:
Mathew Werner Goodman – Group Corporate Communications Manager
Tel: +61 2 9230 7159
Claire Day Cerebral Palsy Alliance – Head of Communications
Tel: + 61 2 9975 8913
About Goodman Goodman Group is an integrated property group with operations throughout Australia, New Zealand, Asia, Europe, the United Kingdom, North America and Brazil. Goodman Group, comprised of the stapled entities Goodman Limited and Goodman Industrial Trust, is the largest industrial property group listed on the Australian Securities Exchange and one of the largest listed specialist investment managers of industrial property and business space globally. Goodman’s global property expertise, integrated own+develop+manage customer service offering and significant investment management platform ensures it creates innovative property solutions that meet the individual requirements of its customers, while seeking to deliver sustainable long-term returns for its Partners.
For more information: www.goodman.com
About Cerebral Palsy Alliance Cerebral Palsy Alliance is an organisation that provides family-centred therapies, life skills programs, equipment and support for people living with cerebral palsy and their families. Our services range from early intervention services for babies, school and mentoring programs for teens to work programs for adults. We respond to the changing needs of our clients based on the latest research, technology and therapies. To ensure people with cerebral palsy have access to high quality and innovative services and programs, Cerebral Palsy Alliance provides professional development and training for employees within the disability sector. We also fund important cerebral palsy research in Australia and overseas through our Research Foundation. Cerebral Palsy Alliance operates from 55 sites throughout metropolitan, regional and rural NSW and the ACT.
For more information: www.cerebralpalsy.org.au
For more information about Steptember: www.steptember.org.au
Australia’s first clinical trial of stem cell infusion from cord blood as a possible treatment for cerebral palsy (CP) is commencing in Melbourne. The safety trial, led by the Murdoch …read more
Australia’s first clinical trial of stem cell infusion from cord blood as a possible treatment for cerebral palsy (CP) is commencing in Melbourne. The safety trial, led by the Murdoch Childrens Research Institute (MCRI), will recruit patients nationally and take place at The Royal Children’s Hospital. Expected to take two years, the study is being funded by the Cerebral Palsy Alliance Research Foundation and Cell Care, Australia’s largest private cord blood bank. It is the first step in a promising process that eventually aims to find out whether cord blood infusion is both safe and efficacious for children with the condition.
Professor Dinah Reddihough, Head of Developmental Disability and Rehabilitation Research at MCRI and lead investigator commented, “We are very excited about the announcement of this study which will primarily assess the safety of using sibling cord blood in children with CP. The study will also make preliminary investigations into changes in motor skills in these children.”
For this safety trial, MCRI will recruit children with CP aged one to 11 years, who have sibling cord blood stored in one of Australia’s family cord blood banks.
“Early-stage clinical studies have suggested that there may be slight improvements in motor function when a child’s own cord blood or unrelated cord blood, has been infused in the setting of CP. This study is assessing sibling cord blood infusion as a possible treatment for children with CP. Siblings have a 25 per cent chance of being a full match and we therefore expect only a small group of children will be eligible for this trial,” said Professor Reddihough.
Cerebral palsy is a physical disability that affects movement and posture. It is a permanent life-long condition and is caused by damage to the developing brain either during pregnancy or shortly after birth. Every 15 hours, an Australian child is born with CP, making it the most common physical disability in childhood.
Professor Iona Novak, Head Of Research, Cerebral Palsy Alliance Research Institute said that “the importance of the study cannot be underestimated”.
“Unfortunately we hear of many Australian children with CP and their families travelling overseas to receive unregulated stem cell treatments at great cost. This study, using cord blood which has been stored under Australian Government regulated conditions, is an important first step towards potentially improving treatment options available for children with CP,” said Professor Novak.
Many Australian families have stored their children’s cord blood in anticipation of future advances in the field. In anticipation of research trials in Australia, Cell Care recently established a free cord blood collection and storage program for siblings of a child with CP which has had strong uptake.
Melbourne mother, Carly Stewart, has three children including eight-year old Lachlan who was diagnosed with CP shortly after birth. Commenting on the start of the trial, Ms Stewart said, “I’m so glad that we made the decision to store both of Lachlan’s siblings’ cord blood in the hope that one day he might benefit. We are excited about this Australian trial commencing and the promising future of this much-talked about treatment. I encourage other families to store their children’s cord blood.”
Media contact: Caitlin Moore, Murdoch Childrens Research Institute
03 8341 6245 or 0452 193 800
Rita Corrente, Cube (on behalf of Cell Care Australia)
0414 552 426